EGFR and hepatocellular carcinoma: Although miR-338-5p/EGFR axis has been shown to inhibit multidrug resistance and cell growth in hepatocellular carcinoma (15), the results of the present study indicate that miR-338-5p/EGFR axis inhibits the metastasis of pancreatic cancer partially dependent on EGF.